Boreal team

Why work with Boreal
Biomanufacturing.

Everything you need to turn cancer and rare disease research into care.

Boreal is an early-phase cell and gene therapy CDMO that delivers the combination of ingenuity, patient access, and brainpower it takes to ignite the spark and propel you to your next success.

Three natural reasons
to choose Boreal.

At some point, the question will come up: “How do we find the cell therapy and viral vector CDMO that we really want to work with?”

If you highly value collaboration, are excited by doing what’s never been done before, and want access to some of the brightest minds in the business, you’ll find Boreal checks all the right boxes. It’s what’s brought clients back to us time and again, to the tune of 300+ clinical batches, 20 GMP products, and participation in clinical trials run across the globe.

Dynamically adapting
to your needs.

When you choose Boreal, you work with a team built for agility; we’re always ready — and willing — to pivot from Plan A to Plan B (or even Plan C) if your science and business objectives change.

Connecting you with
the right resources.

At the point of innovation, the point of care, and all points in between, you’ll find Boreal uniquely prepared to connect you with everyone vital to early-phase success: researchers, innovators, clinicians, and patients.

Providing access to
foundational science leaders.

At Boreal, you get direct access to scientific leaders who’ve been responsible for game-changing innovations in viral vectors and cell therapy. You can draw on this deep well of knowledge to turn your most promising ideas into action.

Boreal team

Discover how your “whys” inspire our “hows.”

Working with the right team can speed the path to success. So let’s start now.

Get Started

What not to expect when
you partner with Boreal.

Every CDMO is different. Just like every development program. Choosing the right partner means finding an organization whose capabilities, expertise, and approach align with your program’s specific needs.

  • We’re not a large multinational CDMO with rigid processes geared towards mass production. We tailor our manufacturing approach to your needs, whether you’re producing a small number of doses for a first-in-human study or preparing for a larger clinical program.
  • With Boreal, you won’t get a CDMO that operates in isolation. Embedded within a leading hospital research institute, we collaborate with clients throughout their development journey, bringing together the expertise of researchers, clinicians, and innovators to help translate promising research into clinical-stage therapies.
  • Don’t expect us to see discovery and development as separate worlds. We understand the excitement of scientific discovery — and the discipline required to translate promising innovations into clinical-stage therapies. Successfully advancing a therapy requires rigorous process development, robust quality systems, and a commitment to quality from the earliest stages of development.
Boreal team at work

Frequently Asked Questions

Our focus is oncology and rare disease, but our early-phase expertise in viral vectors and cell therapies applies to adjacent indications — reach out to discuss your program.

Boreal is located at 501 Smyth Road, Ottawa, ON, embedded within The Ottawa Hospital’s General Campus.

Direct access to clinicians, patients, and hundreds of active trials lets us connect manufacturing to the clinic and streamline your path from bench to bedside.

Yes — through The Ottawa Hospital and our national network partners, we maintain deep relationships with trial sites across North America, Europe, and Asia.

Picking the right CDMO

Your first early-phase win?
Picking the right CDMO.

You’ve got a game-changing idea to treat cancer or rare disease. We’re ready to bring it to life. Let’s get started.